Investigators demonstrated that Neuropeptide Y Receptor Y1 (NPY1R) mediated the inhibitory action of NPY on estradiol-stimulated growth of ER+ breast cancer (BC) cells, and its expression served as a biomarker to predict endocrine sensitivity and survival in ER+ BC patients.
[Scientific Reports]
7992332
{7992332:AAAAAAAA}
apa
50
1
171702
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/